Axa S.A. Iveric Bio, Inc. Transaction History

Axa S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $489,615 - $680,180	-28,400 Closed	0 $0
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $266,960 - $527,956	28,400 New	28,400 $509,000
Q1 2021 May 14, 2021	BUY	$5.08 - $6.89 $68,580 - $93,015	13,500 New	13,500 $83,000
Q3 2020 Nov 13, 2020	SELL	$4.01 - $6.29 $134,335 - $210,715	-33,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.06 - $6.6 $113,651 - $245,130	-37,141 Reduced 52.58%	33,500 $171,000

Q1 2020 May 15, 2020	BUY	$2.83 - $8.44 $50,657 - $151,076	17,900 Added 33.94%	70,641 $243,000
Q4 2019 Feb 18, 2020	BUY	$0.93 - $8.58 $49,049 - $452,517	52,741 New	52,741 $453,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.